KIDNEY INTERNATIONAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2026-03-27 ms6000001999902226 来自广东省

审稿速度:2.0 | 投稿命中率:5.0
经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的

253 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2019-09-01 wangqifjz

投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了

348 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2017-04-22 xh01

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据；
2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据；
2017年4月初第二次修回，3天后接收。
总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！

737 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2024-09-06 ms3000000163783592 来自北京

审稿速度:1.0
偏重的研究方向：肾脏病学
经验分享：2024-8 accept
编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难

126 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2023-11-04 1de6be33m00(暂无匿称) 来自湖南省

投稿命中率:25.0
经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中

276 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2024-10-13 白衣13 来自新南威尔士

记录下状态，投稿letter
11/10, Submited
13/10, Under Review

136 14 举报

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2015-09-13 211.97.5.59

再接再厉！JerryChancw 2015-03-02 发表::
研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事

JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事

649 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2025-04-26 ms3000001769855759 来自江苏省

偏重的研究方向：肾脏病学
经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned

108 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2024-09-25 申达股份来自安徽省

审稿速度:2.0 | 投稿命中率:5.0
经验分享：ME: Morrissey, Patricia
ME: Burgos, Christine
PROD: Not Assigned

Under Review
这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。

130 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2305284, encodeId=5d46230528460, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：kidney international投稿后under review2天就一直awaiting ed decision一周了？拒稿就拒稿，为什么拖拖拉拉的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcc58165037, createdName=ms6000001999902226, createdTime=Fri Mar 27 09:08:42 CST 2026, time=2026-03-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=575685, encodeId=07905e56851b, content=投了5天一直not assigned under review 今天就awaiting ED decision 目测是要悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85b2984971, createdName=wangqifjz, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535826, encodeId=d32b53582610, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2016年11月初投稿，3周发回审稿意见，大修，修稿意见多达4页，要求补充大量数据； 2017年3月初修回，2周发回审稿意见，一位审稿人满意了，另一位审稿人仍要求补充一些数据； 2017年4月初第二次修回，3天后接收。 总体感觉：该杂志编辑处理投稿的速度和审稿速度非常快。审稿人水平很高，且极为认真，提出的意见都很中肯。不过真心挺难投中的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=737, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e42681663, createdName=xh01, createdTime=Sat Apr 22 13:04:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224475, encodeId=be9f22244e57d, content=审稿速度:1.0 偏重的研究方向：肾脏病学 经验分享：2024-8 accept 编辑很好！给的经验很详细！特别热情，但是确实是投稿比较困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b818859301, createdName=ms3000000163783592, createdTime=Fri Sep 06 16:46:32 CST 2024, time=2024-09-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2166685, encodeId=db1121666856a, content=投稿命中率:25.0 经验分享：投稿后1天under review，9天后就awaiting ED desicion了，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0791695708, createdName=1de6be33m00(暂无匿称), createdTime=Sat Nov 04 18:29:37 CST 2023, time=2023-11-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2230613, encodeId=ae24223061371, content=记录下状态，投稿letter 11/10, Submited 13/10, Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Sun Oct 13 13:58:25 CST 2024, time=2024-10-13, status=1, ipAttribution=新南威尔士), GetPortalCommentsPageByObjectIdResponse(id=515294, encodeId=e52e5152949c, content=再接再厉！JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, beContent=JerryChancw 2015-03-02 发表:: 研究方向：盐敏感性高血压;; 接收率：约5% 审稿时间：约1个月 3天被拒，不耽误事, objectType=tool_impact_factor, channel=null, level=null, likeNumber=649, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=211.97.5.59, createdTime=Sun Sep 13 10:10:00 CST 2015, time=2015-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262318, encodeId=166922623183d, content=偏重的研究方向：肾脏病学 经验分享：记录一下时间线 2025.4.20 submit 2025.4.23 under review 2025.4.25 awaiting ed decision. prod:not assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab085705624, createdName=ms3000001769855759, createdTime=Sat Apr 26 02:32:12 CST 2025, time=2025-04-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2227650, encodeId=5a6b222e65014, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：ME: Morrissey, Patricia ME: Burgos, Christine PROD: Not Assigned Under Review 这个状态已经持续24天了，不知道这到底是送外审了还是一直在编辑手中呢？有点捉急。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd35499591, createdName=申达股份, createdTime=Wed Sep 25 17:28:31 CST 2024, time=2024-09-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2172931, encodeId=eafe21e2931ef, content=有没有遇到过，说Data Sharing Statement不足的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8952252832, createdName=FPW, createdTime=Mon Dec 04 21:37:49 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省)]

2023-12-04 FPW 来自江苏省

有没有遇到过，说Data Sharing Statement不足的？

300 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务